Stability and activity of an Enterobacter aerogenes-specific bacteriophage under simulated gastro-intestinal conditions.
A bacteriophage, designated UZ1 and showing lytic activity against a clinically important strain (BE1) of Enterobacter aerogenes was isolated from hospital sewage. The stability and lytic activity against this strain under simulated gastro-intestinal conditions was evaluated. After addition of bacteriophage UZ1 to a liquid feed at gastric pH 2, the phage was immediately inactivated and could not be recovered. However, by use of an antacid to neutralize stomach acidity, no significant changes in phage titer were observed after 2 h incubation at 37 degrees C. After supplementing pancreatic juice and further incubation for 4 h, the phage titer remained stable. The persistence of UZ1 in a mixed microbial ecosystem that was representative for the large intestine was monitored using an in vitro simulation of the human intestinal microbial ecosystem. A pulse administration of bacteriophage UZ1 at a concentration of 10(5) plaque-forming units (PFU)/ml to reactor 3 (which simulates the ascending colon) showed that, in the absence of the host, bacteriophage UZ1 persisted for 13 days in the simulated colon, while the theoretical washout was calculated at 16 days. To assess its lytic activity in an intestinal microbial ecosystem, a green fluorescent protein (gfp)-labeled E. aerogenes BE1 strain was constructed and gfp-specific primers were designed in order to quantify the host strain using real-time PCR. It was observed that bacteriophage UZ1 was able to replicate and showed lytic activity against E. aerogenes BE1/ gfp in an intestinal microbial ecosystem. Indeed, after 17 h a 2 log unit reduction of E. aerogenes BE1/ gfp was measured as compared with the assay without bacteriophage UZ1, while the phage titer increased by 2 log units at an initial multiplicity of infection of 0.07 PFU/colony-forming unit. This is the first report of an in vitro model to study bacteriophage activity in the complex intestinal microbial community.
Verthé
K
K
LabMET, Ghent University, Coupure Links 653, 9000 Ghent, Belgium.
Possemiers
S
S
Boon
N
N
Vaneechoutte
M
M
Verstraete
W
W
D000998:Antiviral Agents / Q000494:pharmacology; D001433:Bacteriolysis; D001435:Bacteriophages / Q000145:classification / Q000302:isolation & purification / Q000502:physiology* / Q000648:ultrastructure; D001647:Bile Acids and Salts / Q000494:pharmacology; D004279:DNA, Viral / Q000302:isolation & purification / Q000378:metabolism; D021902:Enterobacter aerogenes / Q000235:genetics / Q000254:growth & development / Q000302:isolation & purification / Q000821:virology*; D005798:Genes, Bacterial; D017930:Genes, Reporter; D006761:Hospitals; D006863:Hydrogen-Ion Concentration; D007422:Intestines / Q000821:virology; D008954:Models, Biological; D010189:Pancreatic Juice / Q000378:metabolism; D016133:Polymerase Chain Reaction; D012722:Sewage / Q000821:virology; D013696:Temperature; D010948:Viral Plaque Assay; D038301:Virus Inactivation
D000998:Antiviral Agents; D001647:Bile Acids and Salts; D004279:DNA, Viral; D012722:Sewage